Lung Cancer
-
Aoyixin (Limertinib) – NSCLC | HongKong DengYue Medicine
-
Hycamtin (Topotecan Hydrochloride) – Malignancies | HongKong DengYue Medicine
-
ENHERTU (Trastuzumab Deruxtecan) – HER2-driven cancers | HongKong DengYue Medicine
-
YERVOY (Ipilimumab) – Advanced Malignancies | HongKong DengYue Medicine
-
Rybrevant (Amivantamab) – NSCLC | HongKong DengYue Medicine
-
ORPATHYS (Savolitinib Tablets) – NSCLC | HongKong DengYue Medicine
-
Ttarisso (Osimertinib) – NSCLC | HongKong DengYue Medicine
-
Rozlytrek (Entrectinib) – NSCLC | HongKong DengYue Medicine
-
Tarceva (Erlotinib) – NSCLC & Pancreatic Cancer | HongKong DengYue Medicine
-
Ensacove (Ensartinib Hydrochloride Capsules) – Lung Cancer | HongKong DengYue Medicine
-
Daboshu (Sintilimab Injection) – Lung Cancer | HongKong DengYue Medicine
-
Tuoyi (Toripalimab) – Nasopharyngeal Carcinoma | HongKong DengYue Medicine
-
Tafinlar (Dabrafenib Mesylate) – Melanoma & Lung Cancer | DengYue Medicine
-
Firmonertinib Mesilate Tablets – NSCLC | HongKong DengYue Medicine
-
Zegfrovy (Sunvozertinib) | NSCLC | HongKong DengYue Med
-
Rezivertinib – NSCLC | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights